Arunjyoti Bio (ABVL) | Financial Analysis & Statements
Arunjyoti Bio Ventures Ltd. Small-cap Industrials
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
87.1M
Gross Profit
80.7M
92.57%
Operating Income
27.8M
31.87%
Net Income
23.6M
27.13%
EPS (Diluted)
₹0.13
Balance Sheet Metrics
Total Assets
596.2M
Total Liabilities
272.4M
Shareholders Equity
323.8M
Debt to Equity
0.84
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Arunjyoti Bio Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 278.8M | 204.3M | 17.4M | 29.7M | 55.1M |
| Cost of Goods Sold | 114.3M | 85.2M | 15.0M | 28.8M | 48.1M |
| Gross Profit | 164.6M | 119.1M | 2.4M | 895.4K | 7.0M |
| Gross Margin % | 59.0% | 58.3% | 13.8% | 3.0% | 12.7% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 8.6M | 7.0M | 206.0K | 1.5M | 2.6M |
| Other Operating Expenses | 13.6M | 37.8M | 451.0K | 819.0K | 1.1M |
| Total Operating Expenses | 22.2M | 44.8M | 657.0K | 2.3M | 3.6M |
| Operating Income | 19.7M | 7.7M | 1.7M | -2.0M | 963.1K |
| Operating Margin % | 7.1% | 3.8% | 9.5% | -6.8% | 1.7% |
| Non-Operating Items | |||||
| Interest Income | 2.8M | 369.0K | 0 | 0 | 0 |
| Interest Expense | 25.9M | 21.1M | 74.0K | 10.7K | 58.9K |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | -3.4M | -13.0M | 1.6M | 760.2K | 922.5K |
| Income Tax | 14.8M | -9.5M | 410.0K | 197.7K | 239.8K |
| Effective Tax Rate % | 0.0% | 0.0% | 26.0% | 26.0% | 26.0% |
| Net Income | -18.2M | -3.5M | 1.2M | 562.6K | 682.6K |
| Net Margin % | -6.5% | -1.7% | 6.7% | 1.9% | 1.2% |
| Key Metrics | |||||
| EBITDA | 53.0M | 28.2M | 1.7M | 770.9K | 981.3K |
| EPS (Basic) | ₹-0.10 | ₹-0.03 | ₹0.01 | ₹0.00 | ₹0.01 |
| EPS (Diluted) | ₹-0.10 | ₹-0.03 | ₹0.01 | ₹0.00 | ₹0.01 |
| Basic Shares Outstanding | 186381000 | 112990049 | 112990049 | 112984593 | 112984593 |
| Diluted Shares Outstanding | 186381000 | 112990049 | 112990049 | 112984593 | 112984593 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Arunjyoti Bio Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 5.9M | 859.0K | 252.0K | 73.6K | 8.1M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 28.1M | 27.3M | 7.8M | 5.4M | 18.4M |
| Inventory | 26.2M | 29.3M | 8.8M | 0 | 259.5K |
| Other Current Assets | 1.0K | 2.6M | 711.0K | 644.8K | 644.8K |
| Total Current Assets | 148.0M | 112.8M | 55.3M | 10.9M | 32.1M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 71.3M | 45.3M | 0 | 0 | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | - | - | - | - | - |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 15.0M | 12.3M | 0 | 0 | - |
| Total Non-Current Assets | 448.3M | 427.1M | 303.7M | 10.0M | 15.0M |
| Total Assets | 596.2M | 539.9M | 359.1M | 21.0M | 47.0M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 0 | 3.9M | 0 | 167.9K | 13.1M |
| Short-term Debt | 47.6M | 42.2M | 0 | 0 | 0 |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | -1.0K | 4.1M | 1.0K | 239.8K | 239.8K |
| Total Current Liabilities | 52.9M | 50.3M | 15.2M | 937.2K | 27.6M |
| Non-Current Liabilities | |||||
| Long-term Debt | 214.5M | 471.9M | 322.7M | 0 | 0 |
| Deferred Tax Liabilities | 5.0M | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1.0K | 1.0K | -1.0K | 26.6K | 27.3K |
| Total Non-Current Liabilities | 219.5M | 471.9M | 322.7M | 26.6K | 27.3K |
| Total Liabilities | 272.4M | 522.2M | 337.9M | 963.8K | 27.6M |
| Equity | |||||
| Common Stock | 186.4M | 20.7M | 20.7M | 20.7M | 20.7M |
| Retained Earnings | -30.6M | -5.4M | -1.9M | -3.1M | -3.6M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 323.8M | 17.7M | 21.2M | 20.0M | 19.4M |
| Key Metrics | |||||
| Total Debt | 262.1M | 514.1M | 322.7M | 0 | 0 |
| Working Capital | 95.1M | 62.4M | 40.1M | 10.0M | 4.5M |
Balance Sheet Composition
Arunjyoti Bio Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -3.4M | -13.0M | 1.6M | 760.2K | 922.5K |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | 0 | 0 | - |
| Working Capital Changes | -31.8M | 33.4M | -131.8M | 4.4M | 5.0M |
| Operating Cash Flow | -12.1M | 40.9M | -130.3M | 5.1M | 5.9M |
| Investing Activities | |||||
| Capital Expenditures | -58.7M | -233.3M | -191.9M | 0 | 0 |
| Acquisitions | - | - | 0 | 0 | 0 |
| Investment Purchases | - | - | 0 | 0 | 0 |
| Investment Sales | - | - | 0 | 0 | 0 |
| Investing Cash Flow | -58.7M | -233.3M | -191.9M | 0 | 0 |
| Financing Activities | |||||
| Share Repurchases | - | - | 0 | 0 | 0 |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | -256.7M | 143.3M | 322.7M | 0 | 0 |
| Debt Repayment | - | - | - | - | 0 |
| Financing Cash Flow | 73.0M | 184.8M | 322.7M | 0 | 0 |
| Free Cash Flow | -44.2M | -170.2M | -322.5M | -7.8M | -3.1M |
| Net Change in Cash | 2.2M | -7.5M | 588.0K | 5.1M | 5.9M |
Cash Flow Trend
Arunjyoti Bio Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
55.46
Price to Book
4.38
Price to Sales
6.11
PEG Ratio
-0.53
Profitability Ratios
Profit Margin
-6.61%
Operating Margin
8.92%
Return on Equity
-5.63%
Return on Assets
-3.06%
Financial Health
Current Ratio
1.06
Debt to Equity
71.24
Beta
0.21
Per Share Data
EPS (TTM)
₹-0.09
Book Value per Share
₹1.93
Revenue per Share
₹1.47
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| ABVL | 1.6B | 55.46 | 4.38 | -5.63% | -6.61% | 71.24 |
| BLS International | 116.6B | 18.13 | 5.47 | 25.17% | 22.39% | 16.55 |
| CMS Info Systems | 49.8B | 15.62 | 2.13 | 16.43% | 13.02% | 9.54 |
| PDS | 40.5B | 37.65 | 2.38 | 9.14% | 0.82% | 70.40 |
| Intelligent Supply | 38.1B | 272.73 | 1.61 | -3.90% | 99.63% | 1.11 |
| Jaykay Enterprises | 21.2B | 71.51 | 2.04 | 1.45% | 28.79% | 0.15 |
Financial data is updated regularly. All figures are in the company's reporting currency.



